Generic vs Branded Medicines: What You Need to Know
ByAinvest
Monday, Jul 7, 2025 6:36 am ET1min read
India's pharmaceutical industry is valued at $50 billion and expected to grow to $120-130 billion by 2030. Generics drive this growth, contributing 70-80% of India's retail pharma revenue. However, concerns about substandard pharmaceuticals in India have been raised by the Central Drugs Standard Control Organisation. Generic medicines are identical to branded drugs in dosage, strength, and effectiveness, but minor differences in inactive ingredients or packaging may exist. Reputable manufacturers follow strict regulatory protocols and conduct bioequivalence studies to ensure safety and effectiveness. Choosing generics can save 30-90% compared to branded medicines.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet